Immunosuppressive Agents: all 5,940 studies that test it
Page 44 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsCompletedNCT01304836Phase 4
- Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)CompletedNCT01303874Phase 4
- Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate CancerCompletedNCT01303705Phase 1
- Early Cardiac Toxicity of Adjuvant CT in Elderly BC.TerminatedNCT01301040Phase 2
- Clinical Trial Treatment in Lupus NephritisWithdrawnNCT01299922Phase 3
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic CancerCompletedNCT01298713Phase 2
- Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple MyelomaCompletedNCT01296503Phase 3
- Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)Status unknownNCT01295593Phase 1/2
- SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.CompletedNCT01295151Phase 4
- Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®CompletedNCT01294020Phase 2
- Etanercept (Enbrel) in Ankylosing SpondylitisStatus unknownNCT01289743Phase 2
- Etanercept (Enbrel) in Undifferentiated SpondyloarthritisStatus unknownNCT01289730Phase 2
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus NephritisWithdrawnNCT01288664Phase 3
- A Study of the Pharmacokinetics of Golimumab in Chinese Male SubjectsCompletedNCT01288157Phase 1
- Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) TreatmentTerminatedNCT01288131Phase 3
- Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic ArthritisStatus unknownNCT01287715Phase 4
- A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.CompletedNCT01285817Phase 2
- Lapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerStatus unknownNCT01283789Phase 2
- Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell TransplantationCompletedNCT01283776Phase 2
- A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic CancerCompletedNCT01281514Phase 1
- Alternate Dosing Regimens of BG00012 in Healthy VolunteersCompletedNCT01281111Phase 1
- Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal TransplantationTerminatedNCT01276834Phase 4
- A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple MyelomaCompletedNCT01274403Phase 2
- Study on the Safety of Abatacept in Relapsing PolychondritisCompletedNCT01272856Phase 1
- Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA PatientsCompletedNCT01270997Phase 3
- Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant RecipientsWithdrawnNCT01269684Phase 4
- Improving Secretion of Insulin in New Onset Diabetes After Renal TransplantationTerminatedNCT01268995Phase 2
- Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)CompletedNCT01266837Phase 4
- Sirolimus or Vorinostat and Hydroxychloroquine in Advanced CancerCompletedNCT01266057Phase 1
- Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib AloneStatus unknownNCT01263951Phase 2
- Study of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis PatientsCompletedNCT01258712Phase 3
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's LymphomaCompletedNCT01251107Phase 3
- Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to RanibizumabStatus unknownNCT01249937Phase 2
- Efficacy Study of PAD and TAD in Newly Diagnosed Multiple MyelomaStatus unknownNCT01249690Phase 4
- A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior ChemotherapyCompletedNCT01248403Phase 3
- Umbilical Cord Blood Transplant for Children With Lymphoid Hematological MalignanciesWithdrawnNCT01247688Not applicable
- The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia AreataCompletedNCT01246284Not applicable
- Everolimus for Patients With Relapsed/Refractory Germ Cell CancerCompletedNCT01242631Phase 2
- Dendritic Cell-based Immunotherapy Combined With Low-dose Cyclophosphamide in Patients With Malignant MesotheliomaCompletedNCT01241682Phase 1
- Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter TrialStatus unknownNCT01240850Phase 3
- Thymoglobulin Induction in Kidney Transplant RecipientsStatus unknownNCT01239563Phase 3
- Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal ImpairmentCompletedNCT01239459Phase 1
- Hematopoietic Stem Cell Transplantation for MucopolysaccharidosisStatus unknownNCT01238328Phase 2/3
- Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors TherapyStatus unknownNCT01237262Phase 4
- High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating PolyneuropathyWithdrawnNCT01236456Phase 2
- IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor EverolimusWithdrawnNCT01234974Phase 2
- Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's DiseaseCompletedNCT01233570Phase 2
- Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.TerminatedNCT01231854Phase 4
- Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque PsoriasisCompletedNCT01230138Phase 2
- Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast CancerWithdrawnNCT01229605Phase 2
- Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALLCompletedNCT01228331Phase 2/3
- Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast CancerWithdrawnNCT01227408Phase 2
- Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular TargetsSuspendedNCT01226056Phase 1/2
- Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly VolunteersCompletedNCT01225224Phase 1
- A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224418Phase 4
- Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224041Phase 4
- A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy PatientsCompletedNCT01224028Phase 2
- Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal InsufficiencyTerminatedNCT01223755Phase 2/3
- 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer PatientsStatus unknownNCT01222052Phase 3
- Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of AbataceptWithdrawnNCT01221636Phase 1
- Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast CancerWithdrawnNCT01219907Phase 1
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- Thymoglobulin in Unrelated Hematopoietic Progenitor Cell TransplantationStatus unknownNCT01217723Phase 3
- A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix CancerCompletedNCT01217177Phase 1
- Rapamycin In Angiomyolipomas In Patients With Tuberous SclerosisCompletedNCT01217125Phase 4
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue SarcomasStatus unknownNCT01216839Phase 2
- Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed OsteosarcomaStatus unknownNCT01216826Phase 2
- The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis PatientsCompletedNCT01213017Phase 3
- Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With CancerTerminatedNCT01212887Phase 1
- Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)CompletedNCT01212653Phase 4
- Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in RwandaCompletedNCT01211327Phase 4
- A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer PatientsStatus unknownNCT01210768Phase 2
- Tacrolimus Versus Cyclophosphamide as Treatment for Lupus NephritisCompletedNCT01207297Phase 1
- Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic SyndromeCompletedNCT01205087Phase 2
- Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine CarcinomaCompletedNCT01204476Phase 1
- RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell LymphomasCompletedNCT01198665Phase 1/2
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- Open-label, Extension Study of CDP870 in Patients With Rheumatoid ArthritisCompletedNCT01197066Phase 3
- Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly DiagnosedCompletedNCT01194791Phase 2
- Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk NeuroblastomaActive, not recruitingNCT01192555Phase 1/2
- A Study to Evaluate the Drug Interaction of ASP015K and TacrolimusCompletedNCT01190670Phase 1
- RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.WithdrawnNCT01188889Phase 1/2
- Dose Ranging Study to Compare the Efficacy and Safety of Methotrexate in Plaque Type PsoriasisCompletedNCT01187264Phase 4
- Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL)CompletedNCT01186640Phase 2
- An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive RegimensCompletedNCT01183247Phase 4
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor MalignanciesCompletedNCT01182168Phase 1
- A Study to Assess Drug Interaction of ASP015K and MidazolamCompletedNCT01182077Phase 1
- Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)Status unknownNCT01178697Phase 2
- Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers SyndromeWithdrawnNCT01178151Phase 2
- Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.CompletedNCT01177566Phase 4
- High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCompletedNCT01177371Phase 2
- Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 DeficiencyActive, not recruitingNCT01176006Phase 2
- Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic MalignanciesCompletedNCT01175785Phase 2
- Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment StrategyTerminatedNCT01175772Phase 2
- Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine TumorStatus unknownNCT01175096Phase 1/2
- Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus NephritisStatus unknownNCT01172002Not applicable
- Cyclosporine-A Versus Prednisolone for Induction of Remission in Auto-immune HepatitisCompletedNCT01170351Phase 3
- Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung CancerCompletedNCT01167530Phase 1
- Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to LenalidomideCompletedNCT01166113Phase 1/2
- Multicenter Phase II Study to Evaluate the Clinical Activity and the Safety Profile of Everolimus in Marginal Zone B-cell Lymphomas (MZL)CompletedNCT01164267Phase 2